Cargando…

Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 2012;61:2922–2931

Detalles Bibliográficos
Autores principales: Subauste, AR, Das, AK, Li, X, Elliot, B, Evans, C, El Azzouny, M, Treutelaar, M, Oral, E, Leff, T, Burant, CF
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581209/
http://dx.doi.org/10.2337/db13-er03a
_version_ 1782260384238927872
author Subauste, AR
Das, AK
Li, X
Elliot, B
Evans, C
El Azzouny, M
Treutelaar, M
Oral, E
Leff, T
Burant, CF
author_facet Subauste, AR
Das, AK
Li, X
Elliot, B
Evans, C
El Azzouny, M
Treutelaar, M
Oral, E
Leff, T
Burant, CF
author_sort Subauste, AR
collection PubMed
description
format Online
Article
Text
id pubmed-3581209
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-35812092013-03-05 Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 2012;61:2922–2931 Subauste, AR Das, AK Li, X Elliot, B Evans, C El Azzouny, M Treutelaar, M Oral, E Leff, T Burant, CF Diabetes Errata American Diabetes Association 2013-03 2013-02-14 /pmc/articles/PMC3581209/ http://dx.doi.org/10.2337/db13-er03a Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Errata
Subauste, AR
Das, AK
Li, X
Elliot, B
Evans, C
El Azzouny, M
Treutelaar, M
Oral, E
Leff, T
Burant, CF
Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 2012;61:2922–2931
title Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 2012;61:2922–2931
title_full Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 2012;61:2922–2931
title_fullStr Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 2012;61:2922–2931
title_full_unstemmed Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 2012;61:2922–2931
title_short Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 2012;61:2922–2931
title_sort alterations in lipid signaling underlie lipodystrophy secondary to agpat2 mutations. diabetes 2012;61:2922–2931
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581209/
http://dx.doi.org/10.2337/db13-er03a
work_keys_str_mv AT subaustear alterationsinlipidsignalingunderlielipodystrophysecondarytoagpat2mutationsdiabetes20126129222931
AT dasak alterationsinlipidsignalingunderlielipodystrophysecondarytoagpat2mutationsdiabetes20126129222931
AT lix alterationsinlipidsignalingunderlielipodystrophysecondarytoagpat2mutationsdiabetes20126129222931
AT elliotb alterationsinlipidsignalingunderlielipodystrophysecondarytoagpat2mutationsdiabetes20126129222931
AT evansc alterationsinlipidsignalingunderlielipodystrophysecondarytoagpat2mutationsdiabetes20126129222931
AT elazzounym alterationsinlipidsignalingunderlielipodystrophysecondarytoagpat2mutationsdiabetes20126129222931
AT treutelaarm alterationsinlipidsignalingunderlielipodystrophysecondarytoagpat2mutationsdiabetes20126129222931
AT orale alterationsinlipidsignalingunderlielipodystrophysecondarytoagpat2mutationsdiabetes20126129222931
AT lefft alterationsinlipidsignalingunderlielipodystrophysecondarytoagpat2mutationsdiabetes20126129222931
AT burantcf alterationsinlipidsignalingunderlielipodystrophysecondarytoagpat2mutationsdiabetes20126129222931